Bow Capital — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
LinusBio develops precision medicine diagnostics based on exposome sequencing to identify biomarkers for complex conditions including autism spectrum disorder, amyotrophic lateral sclerosis, inflammatory bowel disease, and other diseases.
AI & Machine LearningBiotechDigital HealthMedical DevicesNew York, US
Manish Arora(Founder and CEO)in
Co-investorsGPVGreatPoint VenturesDivergent Investments
Skillit provides an AI-powered hiring platform connecting construction and skilled trade recruiters with vetted craft workers across the United States.
AI & Machine LearningB2B MarketplacesConstruction TechHR TechNew York, US
FRASER PATTERSON(Executive Officer, Director)
BoardJESSE DEVITTE(Director)inRAFI SYED(Director)in
Co-investorsBuilding VenturesGreat North VenturesMetaPropMetaProp VenturesDPR Construction
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.